Irinotecan (Camptosar) in Patients With Advanced Sarcomas

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

August 31, 2007

Study Completion Date

January 31, 2012

Conditions
Sarcoma
Interventions
DRUG

Irinotecan

16 mg/m2 by vein Daily Over 1 Hour x 5 Days

Trial Locations (1)

77030

UT MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00509860 - Irinotecan (Camptosar) in Patients With Advanced Sarcomas | Biotech Hunter | Biotech Hunter